Samsung Electronics today announced a partnership with Alcedis, a digital-first clinical research organization (CRO) specializing in data-driven clinical trials, to translate biometrics collected by wearable devices into meaningful evidence for clinical trials in pharmaceutical and other research organizations, maximizing efficiency in terms of both cost and time.

Wearable technologies have become a widely available and cost-effective way to capture continuous, real-world health data, making them extremely appealing for clinical research. However, many research programs struggle t…